Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
GUMC now offers three clinical trials to study treatments for LBD

GUMC now offers three clinical trials to study treatments for LBD

Cytek Biosciences hits flow cytometry milestone: 40 color analysis from a single sample

Cytek Biosciences hits flow cytometry milestone: 40 color analysis from a single sample

NUS researcher invents novel transfection technique to deliver DNA into immune cells

NUS researcher invents novel transfection technique to deliver DNA into immune cells

Targeting two genetic faults in cancer cells could hold the key to treating leukemia

Targeting two genetic faults in cancer cells could hold the key to treating leukemia

Cytek Biosciences' flow cytometry system achieves 40 color analysis from a single sample

Cytek Biosciences' flow cytometry system achieves 40 color analysis from a single sample

Researchers discover metabolic vulnerability in cancer cells with mutated spliceosomes

Researchers discover metabolic vulnerability in cancer cells with mutated spliceosomes

Two cell mutations contribute to the development of acute myeloid leukemia

Two cell mutations contribute to the development of acute myeloid leukemia

CAR T-cell therapy may be effective in killing solid tumor cells

CAR T-cell therapy may be effective in killing solid tumor cells

Detecting neurocognitive change in children with acute lymphoblastic leukemia

Detecting neurocognitive change in children with acute lymphoblastic leukemia

Study reveals molecular mechanism of cancer malignancy and development of leukemia

Study reveals molecular mechanism of cancer malignancy and development of leukemia

New blood test shows ability to accurately detect numerous types of cancer

New blood test shows ability to accurately detect numerous types of cancer

Combination therapy may offer new therapeutic avenue for previously-treated NSCLC and kidney cancer patients

Combination therapy may offer new therapeutic avenue for previously-treated NSCLC and kidney cancer patients

Investigational drug may offer new treatment option for patients with lung and kidney cancer

Investigational drug may offer new treatment option for patients with lung and kidney cancer

BCG vaccination in childhood could decrease risk of lung cancer

BCG vaccination in childhood could decrease risk of lung cancer

Researchers explore risk of ALL in children with Down syndrome

Researchers explore risk of ALL in children with Down syndrome

Newly synthesized anticancer compound can block cancer signaling mechanism

Newly synthesized anticancer compound can block cancer signaling mechanism

Leukemia drug appears to be effective in treating deadly pediatric brain tumor

Leukemia drug appears to be effective in treating deadly pediatric brain tumor

Study provides new insight into how cells maintain their identity

Study provides new insight into how cells maintain their identity

Discovery of combination protein leads to first-in-human clinical trial for leukemia

Discovery of combination protein leads to first-in-human clinical trial for leukemia

5 million gift will help create Edward P. Evans Center for MDS at Dana-Farber

5 million gift will help create Edward P. Evans Center for MDS at Dana-Farber

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.